Letter to the Editor: “Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents”
Neurocritical Care · 2024
DOI: 10.1007/s12028-024-02060-9 ↗Kurz gefasst
Leserbrief in der Zeitschrift Neurocritical Care, 2024. Verfasst von Caitlyn Wandvik und 2 weiteren Autor:innen. Beteiligte Einrichtung: Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, USA. Hauptthemen laut MEDLINE: Ticagrelor, Clopidogrel, Stents, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, USA.
- Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, UT, USA.
- Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, UT, USA. neuropub@hsc.utah.edu.
ORCID-Profile: Ramesh Grandhi
Zitieren
APA
Wandvik, C., Bounajem, M. T., & Grandhi, R. (2024). Letter to the Editor: “Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents”. Neurocritical Care. https://doi.org/10.1007/s12028-024-02060-9
Vancouver
Wandvik C, Bounajem MT, Grandhi R. Letter to the Editor: “Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents”. Neurocritical Care. 2024. doi:10.1007/s12028-024-02060-9
BibTeX
@article{Wandvik2024,
author = {Wandvik, Caitlyn and Bounajem, Michael T and Grandhi, Ramesh},
title = {Letter to the Editor: “Multicenter Comparison of the Safety and Efficacy of Clopidogrel Versus Ticagrelor for Neuroendovascular Stents”},
journal = {Neurocritical Care},
year = {2024},
doi = {10.1007/s12028-024-02060-9}
}
EUVIMED